A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Institut Paoli-Calmettes
Universitair Ziekenhuis Brussel
Minneamrita Therapeutics LLC
Immix Biopharma, Inc.
Kineta Inc.
Namida Lab
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
Chongqing Precision Biotech Co., Ltd
MiRXES Pte Ltd
Impact Therapeutics, Inc.
Genzada Pharmaceuticals USA, Inc.
Provectus Pharmaceuticals
Blue Note Therapeutics
Moscow Clinical Scientific Center
Main Line Health
Assistance Publique - Hôpitaux de Paris
Weprom
Charite University, Berlin, Germany
Peking University Cancer Hospital & Institute
SpeciCare
MetiMedi Pharmaceuticals
Placon Therapeutics
Xuanwu Hospital, Beijing
Southwest Hospital, China
SPGO Research Mannheim GmbH
Chinese PLA General Hospital
Chinese PLA General Hospital
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rambam Health Care Campus
Poniard Pharmaceuticals